Literature DB >> 11325514

Stromal-epithelial interactions in the progression of ovarian cancer: influence and source of tumor stromal cells.

J A Parrott1, E Nilsson, R Mosher, G Magrane, D Albertson, D Pinkel, J W Gray, M K Skinner.   

Abstract

Stromal cells are essential for the progression of many cancers including ovarian tumors. Stromal cell-epithelial cell interactions are important for tumor development, growth, angiogenesis, and metastasis. In the current study, the effects of normal ovarian bovine stromal cells on ovarian tumor progression was investigated. The hypothesis tested is that ovarian stromal cells will alter the onset and progression of ovarian tumors. Conditioned medium from normal bovine ovarian surface stromal cells was found to stimulate the growth of normal ovarian surface epithelium and had no effect on the growth of human tumor cell lines SKOV3 and OCC1. Human ovarian cancer cell lines, SKOV3 and OCC1, were injected subcutaneously into nude mice to examine tumor progression. Tumor growth in the nude mice was dramatically reduced when normal ovarian surface stromal cells were co-injected with SKOV3 or OCC1 cells. Similar results were obtained with normal bovine or human ovarian stromal cells. In contrast, irrelevant testicular stromal cells and epithelial cells had no effect on tumor growth in the nude mouse. Histological examination of these tumors revealed a characteristic stromal cell component adjacent to epithelial cell colonies. Sections of these tumors were hybridized with species specific genomic probes using fluorescence in situ hybridization to identify cell populations. Epithelial cells were shown to be of human origin (i.e. SKOV3 or OCC1), but stromal cells were found to be primarily murine in origin (i.e. host tissue). No detectable bovine cells were observed in the tumors after one week post-injection. Results suggest that stromal cells are an essential component of ovarian tumors. Interestingly, normal ovarian stromal cells had the ability to inhibit tumor growth, but were not able to survive long-term incubation at the tumor site. The developing tumor appears to recruit host (i.e. murine) stromal cells to invade the tumor and support its growth. In summary, normal ovarian stromal cells can inhibit ovarian tumor progression and the developing tumors recruit adjacent host stroma to become "tumor stroma". The tumor stroma likely develop an altered phenotype that cooperates with the tumorigenic epithelial cells to help promote the progression of ovarian cancer.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11325514     DOI: 10.1016/s0303-7207(01)00436-1

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  24 in total

1.  Reconstruction of functionally normal and malignant human breast tissues in mice.

Authors:  Charlotte Kuperwasser; Tony Chavarria; Min Wu; Greg Magrane; Joe W Gray; Loucinda Carey; Andrea Richardson; Robert A Weinberg
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-29       Impact factor: 11.205

2.  Stromal expression of CD34, α-smooth muscle actin and CD26/DPPIV in squamous cell carcinoma of the skin: a comparative immunohistochemical study.

Authors:  Ayper Kacar; Ata Türker Arikok; Tuba Dilay Kokenek Unal; Evrim Onder; Sema Hucumenoglu; Murat Alper
Journal:  Pathol Oncol Res       Date:  2011-06-15       Impact factor: 3.201

3.  The chemokine growth-regulated oncogene 1 (Gro-1) links RAS signaling to the senescence of stromal fibroblasts and ovarian tumorigenesis.

Authors:  Gong Yang; Daniel G Rosen; Zhihong Zhang; Robert C Bast; Gordon B Mills; Justin A Colacino; Imelda Mercado-Uribe; Jinsong Liu
Journal:  Proc Natl Acad Sci U S A       Date:  2006-10-23       Impact factor: 11.205

4.  Adenovirus i-leader truncation bioselected against cancer-associated fibroblasts to overcome tumor stromal barriers.

Authors:  Cristina Puig-Saus; Alena Gros; Ramon Alemany; Manel Cascalló
Journal:  Mol Ther       Date:  2011-08-23       Impact factor: 11.454

5.  SIK1 couples LKB1 to p53-dependent anoikis and suppresses metastasis.

Authors:  Hailing Cheng; Pixu Liu; Zhigang C Wang; Lihua Zou; Stephanie Santiago; Victoria Garbitt; Ole V Gjoerup; J Dirk Iglehart; Alexander Miron; Andrea L Richardson; William C Hahn; Jean J Zhao
Journal:  Sci Signal       Date:  2009-07-21       Impact factor: 8.192

Review 6.  The Therapeutic Potential of Targeting the HGF/cMET Axis in Ovarian Cancer.

Authors:  Kim Moran-Jones
Journal:  Mol Diagn Ther       Date:  2016-06       Impact factor: 4.074

7.  The CD44+ ALDH+ population of human keratinocytes is enriched for epidermal stem cells with long-term repopulating ability.

Authors:  Akos Z Szabo; Stephen Fong; Lili Yue; Kai Zhang; Lauren R Strachan; Kenneth Scalapino; Maria Laura Mancianti; Ruby Ghadially
Journal:  Stem Cells       Date:  2013-04       Impact factor: 6.277

8.  An experimental platform for studying growth and invasiveness of tumor cells within teratomas derived from human embryonic stem cells.

Authors:  Maty Tzukerman; Tzur Rosenberg; Yael Ravel; Irena Reiter; Raymond Coleman; Karl Skorecki
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-22       Impact factor: 11.205

9.  Bcl-2 expression is altered with ovarian tumor progression: an immunohistochemical evaluation.

Authors:  Nicole S Anderson; Leslie Turner; Sandra Livingston; Ren Chen; Santo V Nicosia; Patricia A Kruk
Journal:  J Ovarian Res       Date:  2009-10-25       Impact factor: 4.234

10.  Blockage of transdifferentiation from fibroblast to myofibroblast in experimental ovarian cancer models.

Authors:  Qin Yao; Xun Qu; Qifeng Yang; David A Good; Shuzhen Dai; Beihua Kong; Ming Q Wei
Journal:  Mol Cancer       Date:  2009-09-27       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.